Janssen Email Formats

Pharmaceutical Manufacturing • Toronto, Ontario, Canada • 2001-5000 Employees

Janssen Email Formats

Janssen uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@its.jnj.com), used 42.2% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@its.jnj.com	42.2%
{first initial}.{last name}	j.doe@janssen.com	12.2%
{last name}{first initial}	doej@its.jnj.com	6.8%
{last name}{last name}	doedoe@its.jnj.com	3.8%
{first name}.{last name}	john.doe@janssen.cl	3.1%

Key Contacts at Janssen

Scott M. Sadel

Director

Alejandro Sepulveda

Scientific Director

Mark Wade

Director Clinical Project Scientist

Kanji Ganeshan

Associate Director, Regulatory Affairs Cmc

Heather Reilly

Director Emerging Technology

Swa Van De Weyer

Director Gpsg Global Compliance Emea

Greet Teuns

Scientific Director Toxicology - Expert Safety Pharmacology Cns And Drug Abuse

Jim Kulp

Director, Product Quality Management Quality Integrator

John Large

Director Customer Engagement Strategy And Operations

Thomas Rammeloo

Senior Director Technology And Engineering

Company overview

Headquarters	19 Green Belt Dr, Toronto, Ontario M3C, CA
Website	janssen.com
NAICS	3254
Keywords	Healthcare, Life Sciences, Pharmaceuticals, Innovation
Employees	2001-5000
Socials

About Janssen

Janssen Inc. (Canada) is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. We are working to create a world without disease by transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Janssen’s commitment to patients and our role as a leader and stakeholder in Canada’s healthcare system means we are actively engaged on healthcare policy matters. Our healthcare policy priorities focus on three areas: 1. Ensuring Canadians Get the Best Medicines 2. Showing the Value That Innovative Medicines Provide to Canada’s Healthcare System 3. Advocating for Continued Investment in Canada’s Life Sciences Sector We believe dialogue among governments, public and private payers, healthcare professionals, the innovative pharmaceutical industry and patients is necessary to create a healthcare system that benefits all Canadians. Learn more at www.janssen.com/canada. Follow us on Twitter @JanssenCanada.